Patents by Inventor Delphine Labit

Delphine Labit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIR domain binding compounds
    Patent number: 8575113
    Abstract: The present invention is directed towards an isomer, an enantiomer, a diastereoisomer, or a tautomer of a pyrrolidine compound represented by Formula I: in which the substituents R1, R1a, R2, R2a, R3, A and Q are defined herein; or a prodrug, or a salt thereof, and which bind to IAP BIR domains. In particular, the compounds are useful in treating proliferative disorders such as cancer.
    Type: Grant
    Filed: June 28, 2010
    Date of Patent: November 5, 2013
    Assignee: Pharmascience Inc.
    Inventors: Scott Jarvis, Alain Boudreault, Patrick Bureau, James B. Jaquith, Alain Laurent, Delphine Labit
  • BIR DOMAIN BINDING COMPOUNDS
    Publication number: 20100292269
    Abstract: The present invention is directed towards an isomer, an enantiomer, a diastereoisomer, or a tautomer of a pyrrolidine compound represented by Formula I: in which the substituents R1, R1a, R2, R2a, R3, A and Q are defined herein; or a prodrug, or a salt thereof, and which bind to IAP BIR domains.
    Type: Application
    Filed: June 28, 2010
    Publication date: November 18, 2010
    Applicant: AEGERA THERAPEUTICS, INC.
    Inventors: Scott Jarvis, Alain Boudreault, Patrick Bureau, James Jaquith, Alain Laurent, Delphine Labit
  • BIR domain binding compounds
    Patent number: 7772177
    Abstract: The present invention is directed towards an isomer, an enantiomer, a diastereoisomer, or a tautomer of a pyrrolidine compound represented by Formula I: in which the substituents R1, R1a, R2, R2a, R3, A and Q are defined herein; or a prodrug, or a salt thereof, and which bind to IAP BIR domains. In particular, the compounds are useful in treating proliferative disorders such as cancer.
    Type: Grant
    Filed: May 16, 2006
    Date of Patent: August 10, 2010
    Assignee: Aegera Therapeutics, Inc.
    Inventors: Scott Jarvis, Alain Boudreault, Patrick Bureau, James Jaquith, Alain Laurent, Delphine Labit
  • BIR domain binding compounds
    Publication number: 20060264379
    Abstract: The present invention is directed towards an isomer, an enantiomer, a diastereoisomer, or a tautomer of a pyrrolidine compound represented by Formula I: in which the substituents R1, R1a, R2, R2a, R3, A and Q are defined herein; or a prodrug, or a salt thereof, and which bind to IAP BIR domains.
    Type: Application
    Filed: May 16, 2006
    Publication date: November 23, 2006
    Inventors: Scott Jarvis, Alain Boudreault, Patrick Bureau, James Jaquith, Alain Laurent, Delphine Labit